Coronary artery disease (CAD) accounts for 600,000 deaths annually in the United States and is the leading cause of death for both men and women around the world. Treatment of hypercholesterolemia has been proven to decrease both morbidity and mortality of CAD. Primary and secondary prevention of CAD is based on controlled LDL cholesterol levels. Patient's beliefs related to lipid lowering medications impacts adherence to these medications. Influences on health are also impacted by place of residence. Negative influences on total health care are based on barriers present in rural communities. The use and acceptance of these medications by rural populations are essential. This pilot project begins to fill knowledge gaps related to rural patients beliefs about medication adherence.
Scientific evidence related to the effectiveness of lipid lowering medications for the treatment of hypercholesterolemia abounds. Statin drugs, the most effective for lowering cholesterol levels, work by inhibiting HMG CoA (Calderon et al., 2010; Cross & Franks, 2005; Foley, Vasey, Berra, Alexander, & Markson, 2005; Hachem & Mooradian, 2006; Schedlbauer et al, 2010) . This synthesis reduction decreases cholesterol content in the liver which lowers serum LDL cholesterol. The drugs from the statin category currently available reduce LDL levels approximately 30-50% in clinical trials (Besseling, van Capelleveen, Kastelein, & Hovingh, 2013) . Achieved control of LDL levels with statin medications reduces the relative risk of CAD as much as 35% (Alla et al., 2013) .
Treatment to achieve goals often requires additional tests, and office visits with changes in medication therapy, frequently leading to decreased medication adherence (Foley et al., 2005) . As statin drugs are titrated to achieve therapeutic goals, maximum statin doses come with increased side effects, including rhabdomyolosis (Hachem & Mooradian, 2006) . At the same time, reports in the literature suggest poor medication adherence to HMG CoA reductase inhibitors continues (Harrison et al., 2013) . For years research has shown patients fall short of the National Cholesterol Education Program (NCEP) standards for effective treatment of hypercholesterolemia (Besseling et al., 2013) . One study in a primary care clinic outside of a large urban city found medication adherence to fall below 30%. Fewer than half of patients achieve cholesterol goals with the initial statin dose (Chi, 2014) . Medication adherence in the treatment of hypercholesterolemia Online Journal of Rural Nursing and Health Care, 15(2) http://dx.doi.org/ 10.14574/ojrnhc.v15i2.367 8 has been shown to significantly lower morbidity and mortality related to CAD (Besseling et al., 2013) .
Rural populations experience many disparities in the utilization of health care (Hartley, 2004) . These disparities in rural areas are associated with social status, income, occupation, education, and place of residence. Negative influences on total health care are based on the barriers present in these rural communities. Water quality, agricultural methods, forestry, or mining can also impact health care for rural residents. Access to health care is impacted by decreased numbers of providers and transportation issues related to distance to receive care (Hartley, 2004) .
Vehicle ownership has been associated with increased utilization of health care services (Hartley, 2004) . Rural populations had diminished resources available to allocate to vehicle ownership inhibiting access. Public transportation also remains absent in rural areas. Additional barriers present in rural areas are a lack of insurance and costs related to health care. Uninsured and underinsured populations may struggle with co-pays, high deductibles, and prescription drug cost. Decreased numbers of health care providers is prevalent in rural areas (Pieh-Holder, Callahan, & Young, 2012) . Access to care and the limitations caused by rural life style can complicate diagnosis, treatment, and follow up in this population.
Conditions seen in the rural demographic constitute a unique set of challenges.
Access to care and the limitations caused by rural life style can complicate diagnosis, treatment, and follow up in this population. This pilot project begins to fill knowledge gaps related rural patients beliefs about medication adherence.
Purpose
Online Journal of Rural Nursing and Health Care, 15(2) http://dx.doi.org/ 10.14574/ojrnhc.v15i2.367 9 The purposes of this pilot project were to describe rural patient's (a) belief's about high cholesterol and cholesterol lowering medications, (b) their adherence to taking these medications, and (c) relationships between adherence and beliefs.
Methods

Conceptual Framework
Donabedian provides an excellent framework to explore beliefs affecting medication adherence in the treatment of hypercholesterolemia. This model can be applied to the rural population to assist the primary investigator in understanding the unique challenges in this specialized population. Examination of beliefs related to medication adherence with statin medications in the treatment of hypercholesterolemia can be achieved through review of the structure, process, and outcomes as delineated by Donabedian (Driel, Sutter, Christiaens, & Maeseneer, 2005) .
Design and Setting
A descriptive survey approach was used to explore rural dwelling patients' at a primary care clinic in rural Georgia. The population of the county is 11,346, with the following ethnic composition: 89% Caucasian, 10% African American, and 1% Hispanic. 
Measures
Three separate forms were used to collect information in this project, a demographic questionnaire, The Morisky Scale, and The Habit Survey.
The Lastly, participants were asked to indicate if they had ever been diagnosed with heart disease, had a heart attack, coronary angioplasty, coronary stent, coronary artery bypass surgery, or chest pain.
The Morisky scale was used to assess the patient's beliefs about medications. The purpose of the Morisky scale is to identify the patient's beliefs and pinpoint persons with low adherence (Bharmal et al., 2009; Bondesson, Hellstrom, Eriksson, & Hoglund, 2009; Morisky, Ang, Krousel-Wood, & Ward, 2008; Shalansky, Levy, & Ignaszewski, 2004) .
Initially, reliability and validity of the Morisky Survey were established in a study of patients diagnosed with hypertension (Bharmal et al., 2009; Morisky et al., 2008) .
Following the successful use of the tool with patients diagnosed with hypertension, the scale has been utilized in studies which did not contain a homogenous group.
Modifications to the Morisky Survey allows for assessment about patient beliefs and medication adherence. Bondesson et al. (2009) suggest the scale should be tailored to specific medicines or groups of medicines. Consequently, the format of the tool used in 
Data Collection
Data collection occurred over a two month period. Initial identification of eligibility was established by the primary investigator by reviewing a list of patients scheduled at the clinic on the days the study was conducted. A certified medical assistant offered each patient the option of participation, with explanation participation would not impact the care provided at the clinic. Further explanation emphasized to the patients there would be no penalty based on the decision not to participate. Dropping out at any time was acceptable and carried no penalty or consequence to the patient, and there was no impact to care received at the clinic. Patients who agreed to participate were then given the project packet with the study instruments. All patients who were approached agreed to participate in the study.
Participants were instructed to complete the forms in the packet onsite at the clinic and to return the packet to the medical assistant. The participant was also given the option of taking the forms home to return them by the postal service. An addressed stamped envelope accompanied the packet if patients elected this option. Inclusion in the study was not affected based on completion onsite or offsite. Participants were given a $3 gift card to a local grocery store redeemable for purchases of any items at the patient's 
Description of the Sample
The convenience sample was obtained at a rural Georgia clinic. Permission for the study was granted through the Mercer University Institutional Review Board (IRB). The study protocol number is H1112300. The inclusion criteria consisted of a diagnosis of hypercholesterolemia, documentation of a prescribed statin medication, age of at least 18 years, mental capacity to self-administer medication, and ability to understand and sign the study consent form. The study forms packet was available in English only. Exclusion criteria included the inability to read or speak English. The study also excluded any persons who were incarcerated or residents of nursing homes, as staff at these facilities administer the prescribed medications.
Data for the 30 participants were analyzed. Descriptive statistics were used to describe the sample. The age range of the participants was from 35-81 years with a mean of 54.8 years of age. The majority, 73.3%, n=22 were female and 26.7%, n=8, were male.
Time since diagnosis of high cholesterol ranged from 1-10 years with a mean of 4.1 years. . Thirty six percent (n=11) of the group reported they had been diagnosed with CAD. The group was predominantly white, at 86.7% (n=26) and 13.3% (n=4) were black. These proportions are congruent with the demographics of the area. The level of participant's formal education ranged from middle school to college attendance, with 60% reporting high school graduation. The study participants report significantly higher high school graduation rates than the published demographics of the area where only 34% had completed high school. 
Findings Patient Adherence to Cholesterol Lowering Medications
The Morisky Scale addressed the patient's adherence to their prescribed cholesterol medications. Table 1 reports participants responses to each of the 7 yes/no questions in the Morisky Scale. The two questions indicating the highest levels of non-adherence were "do you sometimes forget to take your medication" and "then traveling, do you sometimes forget to bring your medications along".
The final question on the Morisky Scale asked participants about remembering to take all of their medications. The format of this question was a Likert scale. Participants were asked "how often do you have difficulty remembering to take all your medications?" The responses were as follows: never/rarely 30% (n = 9), once in a while 23% (n = 7), sometimes 26% (n = 8), usually 17% (n = 5), and all the time 3% (n = 1).
Indicating almost 80% of participants has difficulty remembering to take their medications at least some of the time.
Scoring of the Morisky Scale is determined by the number of "yes" answers. Totals of 0 -1 "yes" responses indicates high adherence. Medium adherence is scored as 2 -3 yes responses, and 4 or more yes responses indicates low adherence. Analysis of the Morisky scale revealed a mean score of less than six for 70% (n=21) of the participants placing them into a category of low adherence.
Patients Beliefs about Cholesterol Lowering Medications
The HABIT tool examining patients' beliefs, the range of scores from one-strongly disagree, to five-strongly agree was utilized. Calculations were completed on the responses of the participants. Nursing and Health Care, 15(2) http://dx.doi.org/ 10.14574/ojrnhc.v15i2.367 When participants were asked about a CAD history, 63% (n = 19) believed they had no CAD, and 36% (n = 11) confirmed a prior diagnosis of CAD. Regarding the patients' belief about statin drug efficacy, 93% (n = 28) stated they agreed or strongly agreed cholesterol drugs work. When asked if the patient wonders whether or their cholesterol medication is working 70% (n = 23) selected agree or strongly agree. Analysis of the HABIT beliefs questionnaire revealed patients had a slightly stronger belief that higher doses would lead to more severe side effects. Inquiry related to beliefs about side effects revealed 73% (n = 22) of participants believed increasing dose of cholesterol medications may lead to muscle aches. Beliefs relating cholesterol and impact on health demonstrated that 96% (n = 29) believe high cholesterol increases the risk of a heart attack.
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Additionally 93% believe lowering cholesterol would reduce the chances of a heart attack Online Journal of Rural Nursing and Health Care, 15(2) http://dx.doi.org/ 10.14574/ojrnhc.v15i2.367 17 in the future. Fifty six percent (n = 19) saw cholesterol as serious of a problem as hypertension and diabetes while 43% (n = 13) saw cholesterol as a less serious problem. 
Relationships between Beliefs and Adherence
Tests were completed comparing the various items with two significant findings.
Item analysis with Spearman's rho correlation revealed two specific statements Online Journal of Rural Nursing and Health Care, 15(2) http://dx.doi.org/ 10.14574/ojrnhc.v15i2.367 18 significantly associated with better adherence. First "In general, do you think cholesterol lowering drugs work?" p=.015. Also the statement "People with high cholesterol are more likely to have a heart attack than people with low cholesterol" p=.035 was related to better adherence with cholesterol lowering medications.
Discussion
The purpose of this research was to examine patient's beliefs about high cholesterol and cholesterol lowering medications, their adherence to taking these medications, and relationships between adherence and beliefs. The findings demonstrate the relationship between beliefs about statin medications for the treatment of hypercholesterolemia and increased medication adherence with these medications. Rates of adherence to cholesterol medications demonstrated in this study are consistent with findings in other studies (Benner et al., 2009; Besseling et al., 2013; Bondesson et al., 2009; Chi, 2014; Harrison et al., 2013; Schedlbauer et al, 2010) Reponses by participants also found adherence to their other medications was at a slightly higher rate. Contributing factors to low adherence include not taking medications when traveling and forgetfulness. muscle aches. This data parallels findings already published related to increased dosing not being tolerated by many patients (Besseling et al., 2013; Harrison et al., 2013) .
Beliefs related to high cholesterol and cardiac conditions found significant numbers of the group believed high cholesterol increased the risk of a heart attack. Similarly, the belief prevailed; lowering cholesterol lowered the risk of a heart attack. The respondents were nearly equally divided on the belief on whether high cholesterol is as significant a health risk as diabetes and high blood pressure. This is difficult to explain based on patient's reporting better adherence to medications treating those conditions than to the medications treating cholesterol.
Implications
The small size of this pilot study and the convenience sample hamper these findings from being extended to other populations. Additionally, the Morisky Scale was modified from the original version for this study. The findings can inform care for providers in rural areas similar to the sample used for this study. The issue of adherence should be addressed at the time of diagnosis and reinforced throughout treatment. As suggested by Harrison et al. (2013) , these conversations should begin as early as possible and be individualized to each patient's situation. Discussions with patients should incorporate strategies promoting adherence. Strategies for remaining adherent while traveling, in the absence of symptoms, and preventing forgotten doses are great examples. This education should focus on the crucial role of treating hypercholesterolemia in the management and prevention of CAD. Consideration and discussion should be given to the problem of symptomless diagnoses such as hypercholesterolemia, and the lack of motivation to adhere to daily treatment. The essential role of statins in treatment should begin as early Online Journal of Rural Nursing and Health Care, 15(2) http://dx.doi.org/ 10.14574/ojrnhc.v15i2.367 20 as testing for the condition. As suggested by Besseling and colleagues (2013) , established evidence based guidelines are available and should be used upon diagnosis with each patient (NICE, 2006; SIGN, 2007) . Presentation of the facts related to optimal benefit from statin therapies, reducing morbidity and mortality from CAD, and preventing heart attack are all vital.
Issues faced by rural communities including access to care, low income, and uninsured or underinsured all may impact adherence. Suggested areas of patient education may include feasibility of follow up visits, the cost of medications, and insurance coverage. Additionally, teaching patients the rational of monitoring CAD and cholesterol, along with improvement strategies is vital (Besseling et al, 2013; Harrison et al., 2013) .
Efforts are needed to provide the vital information related to CAD and cholesterol in rural communities. Strategies could include taking advantage of access to the population through religious and civic groups or workplace. Increasing the public's knowledge can result in increased adherence with cholesterol lowering medications, as evidenced in this study.
